Search Results

Filter
  • 1-10 of  197,399 results for ""COVID-19""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The characteristics of BCR-CDR3 repertoire in COVID-19 patients and SARS-CoV-2 vaccinated volunteers.

  • Authors : Xiao J; Department of Immunology, Center of Immunomolecular Engineering, Innovation & Practice Base for Graduate Students Education, Zunyi Medical University, Zunyi, Guizhou, China.; Fushun People's Hospital, Zigong, Sichuan, China.

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans SARS-CoV-2 variants

  • Source: Journal of medical virology [J Med Virol] 2024 Mar; Vol. 96 (3), pp. e29488.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print Cited Medium: Internet ISSN: 1096-9071

Record details

×
Academic Journal

Effectiveness of primary series, first, and second booster vaccination of monovalent mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections and severe diseases during the SARS-CoV-2 omicron BA.5 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS).

  • Authors : Maeda H; Department of Respiratory Infections, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.; Department of Clinical Tropical Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Expert review of vaccines [Expert Rev Vaccines] 2024 Jan-Dec; Vol. 23 (1), pp. 213-225. Date of Electronic Publication: 2024 Feb 08.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101155475 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Attitudes and perceptions toward COVID-19 virus and vaccines among a Somali population in Northern Wisconsin.

  • Authors : Alasagheirin M; College of Nursing and Health Sciences, University of Wisconsin-Eau Claire, Eau Claire, Wisconsin.; Canales MK

Subjects: SARS-CoV-2* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans

  • Source: Public health nursing (Boston, Mass.) [Public Health Nurs] 2024 Jan-Feb; Vol. 41 (1), pp. 151-163. Date of Electronic Publication: 2023 Nov 16.Publisher: Blackwell Scientific Publications Country of Publication: United States NLM ID: 8501498 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Pre-existing cross-reactive neutralizing activity against SARS-CoV-2 and seasonal coronaviruses prior to the COVID-19 pandemic (2014-2019) with limited immunity against recent emerging SARS-CoV-2 variants, Vietnam.

  • Authors : Nguyen TTN; Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan; Program for Nurturing Global Leaders in Tropical and Emerging Communicable Diseases, Nagasaki University, Nagasaki, Japan

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; COVID-19*/COVID-19*/COVID-19*/epidemiology; Humans SARS-CoV-2 variants

  • Source: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Feb; Vol. 139, pp. 109-117. DatePublisher: Elsevier Country of Publication: Canada NLM ID: 9610933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3511

Record details

×
Academic Journal

COVID-19 vaccination produces exercise-responsive SARS-CoV-2 specific T-cells regardless of infection history.

  • Authors : Smith KA; School of Nutritional Sciences and Wellness, The University of Arizona, Tucson, AZ 85721, USA.; Zúñiga TM

Subjects: SARS-CoV-2* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans

  • Source: Journal of sport and health science [J Sport Health Sci] 2024 Jan; Vol. 13 (1), pp. 99-107. Date of Electronic Publication: 2023 Jul 01.Publisher: Shanghai University of Sport Country of Publication: China NLM ID: 101606001 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Efficacy of adjuvant-associated COVID-19 vaccines against SARS-CoV-2 variants of concern in randomized controlled trials: A systematic review and meta-analysis.

  • Authors : Cheng MQ; Department of Reproductive Medicine, The Pu'er People's Hospital, Pu'er, China.; Weng ZY

Subjects: SARS-CoV-2* ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Alum Compounds*SARS-CoV-2 variants

  • Source: Medicine [Medicine (Baltimore)] 2024 Feb 16; Vol. 103 (7), pp. e35201.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Oral administration of a recombinant modified RBD antigen of SARS-CoV-2 as a possible immunostimulant for the care of COVID-19.

  • Authors : Valdez-Cruz NA; Departamento de Biología Molecular y Biotecnología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Cd. Universitaria, Coyoacán, Ciudad de Mexico, México. AP. 70228, CP. 04510, México, D.F, Mexico. .; Centro de Nanociencias y Nanotecnología, Universidad Nacional Autónoma de México, Km 107 Carretera, 22860, Tijuana-Ensenada, Baja California, Mexico. .

Subjects: SARS-CoV-2* ; COVID-19*; Animals

  • Source: Microbial cell factories [Microb Cell Fact] 2024 Feb 06; Vol. 23 (1), pp. 41. Date of Electronic Publication: 2024 Feb 06.Publisher: BioMed Central Country of Publication: England NLM ID: 101139812 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2859

Record details

×
Academic Journal

Durability and cross-reactive immune memory to SARS-CoV-2 in individuals 2 years after recovery from COVID-19: a longitudinal cohort study.

  • Authors : Guo L; National Health Commission Key Laboratory of Systems Biology of Pathogens and Christophe Mérieux Laboratory, National Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; Key Laboratory of Respiratory Disease Pathogenomics, Chinese Academy of Medical Sciences, Beijing, China.

Subjects: SARS-CoV-2* ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; Spike Glycoprotein, Coronavirus*SARS-CoV-2 variants

  • Source: The Lancet. Microbe [Lancet Microbe] 2024 Jan; Vol. 5 (1), pp. e24-e33. Date of Electronic Publication: 2023 Dec 01.Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101769019 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

New anti-SARS-CoV-2 aminoadamantane compounds as antiviral candidates for the treatment of COVID-19.

  • Authors : de Almeida Marques DP; Laboratório de Virologia Básica e Aplicada (LVBA), Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.; Andrade LAF

Subjects: SARS-CoV-2* ; COVID-19*; Chlorocebus aethiops SARS-CoV-2 variants

  • Source: Virus research [Virus Res] 2024 Feb; Vol. 340, pp. 199291. Date of Electronic Publication: 2023 Dec 14.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8410979 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B.1.1.529) wave in 2022 in China: a longitudinal cohort study.

  • Authors : Zhang H; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship hospital, Capital Medical University, Beijing, China; National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.

Subjects: SARS-CoV-2* ; COVID-19*; Humans

  • Source: The Lancet. Respiratory medicine [Lancet Respir Med] 2024 Jan; Vol. 12 (1), pp. 55-66. Date of Electronic Publication: 2023 Nov 21.Publisher: Elsevier Country of Publication: England NLM ID: 101605555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2619

Record details

×
  • 1-10 of  197,399 results for ""COVID-19""